Successful Deals with PwC: Acino to acquire M8 Pharmaceuticals

Acino, a Swiss pharmaceutical company, entered into an agreement to acquire M8 Pharmaceuticals, a portfolio company of Montreux Growth Partners. The PwC Deals team, led by Luca Borrelli, supported Acino with Financial Due Diligence, SPA advise, Tax Due Diligence and Structuring, Pension Due Diligence, as well as Deal Analytics.

M8 Pharmaceuticals is a fast-growing specialty biopharmaceutical company, headquartered in Mexico City and focused on licensing, marketing, and distributing innovative and established medicines in Mexico and Brazil. M8 Pharmaceuticals has a highly successful record of signing exclusive licensing agreements with large pharmaceutical and biotech companies for the rights to market and commercialize products in Mexico and Brazil. The company brings a portfolio of well-known proven brands and innovative medicines, a best-in-class deal-making platform, and an outstanding reputation among its partners. Moreover, it has built a large pipeline across a broad range of key therapeutic areas, including CNS, cardiometabolism, respiratory, gastroenterology, oncology and hematology, and rare diseases.

Through this acquisition, Acino will enter the two largest pharmaceutical markets in Latin America, significantly expanding its geographic footprint and strengthening its position in the region. The acquisition will complement Acino’s existing Latin American division, which operates across eight countries.


The PwC team

Financial due diligence / SPA advice

  • Luca Borrelli (Partner)
  • Saad Mammo (Director)
  • Felix Peters (Senior Associate)
  • Daniel Ammann (Associate)

Tax due dilligence and structuring

  • Claire Manders Avanzini (Partner)
  • Daniel Schoenenberger (Managing Director)
  • Juliette Buob (Senior Manager)
  • Ariel Gruenewald (Senior Manager)
  • Manuel Ulrich (Senior Manager)

Deal Analytics

  • Simon Malin (Partner)
  • Verena Diestelkaemper (Senior Manager)
  • Balazs Vaghy (Associate)

Financial and Tax international

  • Begona Vizcaino (Partner)
  • Leila Fernandes (Partner)
  • Jonathan Fotzler (Partner)
  • Oscar Navarro Ousset (Director)
  • Additional support from PwC Mexico, Brazil and US

 

Successful Deals with PwC

{{filterContent.facetedTitle}}

{{contentList.dataService.numberHits}} {{contentList.dataService.numberHits == 1 ? 'result' : 'results'}}
{{contentList.loadingText}}

Contact us

Luca Borrelli

Luca Borrelli

Partner, Deals Pharma and Life Sciences Leader, PwC Switzerland

Tel: +41 58 792 22 78